162 related articles for article (PubMed ID: 6482311)
1. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
Herz R; Rössle M; Bonzel T; Keller E; Gerok W
Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
[TBL] [Abstract][Full Text] [Related]
2. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
[TBL] [Abstract][Full Text] [Related]
3. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
[TBL] [Abstract][Full Text] [Related]
4. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
Li S
Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
[TBL] [Abstract][Full Text] [Related]
5. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
6. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
8. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine does not reduce liver blood flow in cirrhosis.
Henderson JM; Ibrahim SZ; Millikan WJ; Santi M; Warren WD
Hepatology; 1983; 3(6):919-22. PubMed ID: 6629321
[TBL] [Abstract][Full Text] [Related]
10. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
Eriksson LS; Law DH; Sato Y; Wahren J
Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
[TBL] [Abstract][Full Text] [Related]
11. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
13. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Navasa M; Chesta J; Bosch J; Rodés J
Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
[TBL] [Abstract][Full Text] [Related]
14. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
Pind ML; Bendtsen F; Kallemose T; Møller S
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.
Møller S; la Cour Sibbesen E; Madsen JL; Bendtsen F
J Gastroenterol Hepatol; 2019 Jun; 34(6):1093-1099. PubMed ID: 30221390
[TBL] [Abstract][Full Text] [Related]
17. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
Vorobioff J; Carnovale C; Topol R; Picabea E; Villavicencio R; Tanno H; Audano M; Audano G
Acta Gastroenterol Latinoam; 1984; 14(3):229-34. PubMed ID: 6537116
[TBL] [Abstract][Full Text] [Related]
18. Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.
Vinel JP; Caucanas JP; Combis JM; Cales P; Voigt JJ; Pascal JP
J Hepatol; 1989 May; 8(3):302-7. PubMed ID: 2732444
[TBL] [Abstract][Full Text] [Related]
19. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
20. Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
J Clin Gastroenterol; 1991 Aug; 13(4):424-31. PubMed ID: 1918848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
